Product Information
PIMOZIDE 1 MG TABLET is a generic product labeled by Endo USA Inc., priced at $1.2378 per EA under NDC 49884034701. Its NADAC has been published 255 times since May 18, 2016.
Strength
1 mg/1
Manufacturer
Endo USA Inc.NDC
49884034701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PIMOZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204521On Market Since
9/28/2015
Pharmacological Classes
Price Statistics
The NADAC for PIMOZIDE 1 MG TABLET has been published 255 times since May 18, 2016, and over the history we have for it it has declined 16.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2378 per EA |
|---|---|
| All-time high | $1.4781 (Jun 15, 2016) |
| All-time low | $1.1466 (Jul 17, 2024) |
| 52-week high | $1.2974 |
| 52-week low | $1.2377 |
| Median price | $1.3345 |
| Average price | $1.3133 |
| Largest weekly change | -8.4% (Apr 17, 2024) |
| Weeks tracked | 255 |
| Tracking since | May 18, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Pimozide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PIMOZIDE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIMOZIDE 1 MG TABLET, manufactured by Endo USA Inc., is $1.2378 per EA (NDC 49884034701), effective Jun 24, 2026.
How has the price of PIMOZIDE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIMOZIDE 1 MG TABLET has declined 16.3%. It has been tracked across 255 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for PIMOZIDE 1 MG TABLET?
Since May 18, 2016, the NADAC for PIMOZIDE 1 MG TABLET has ranged from a low of $1.1466 (Jul 17, 2024) to a high of $1.4781 (Jun 15, 2016), with a median of $1.3345 per EA.
Are there cheaper alternatives to PIMOZIDE 1 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PIMOZIDE 1 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PIMOZIDE 1 MG TABLET?
PIMOZIDE 1 MG TABLET (NDC 49884034701) is labeled by Endo USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification